Education

Education

Fear Over Facts: The Market’s Mistake on Telix

When biotech headlines scream “SEC subpoena,” panic can quickly outweigh perspective. But beneath the sell-off frenzy surrounding Telix Pharmaceuticals’ recent regulatory disclosure lies a compelling opportunity masked by fear.

Telix’s stock has been pummeled after announcing an SEC inquiry— a routine regulatory request, followed by a routine opportunistic law firm “investigation” are simply the cost of success in a high-profile sector, not a red flag

Education

US Strike on Iran Timeline: Main Events (Last 48 Hours)

In the last 48 hours, the US, in close coordination with Israel, conducted unprecedented airstrikes on Iranian nuclear sites, escalating the regional conflict. Both sides are bracing for further retaliation, with international actors urging restraint and diplomacy amid heightened military readiness and legal debate in Washington

Scroll to Top